These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 23907518)

  • 1. Current treatment of locoregional recurrence of melanoma.
    Squires MH; Delman KA
    Curr Oncol Rep; 2013 Oct; 15(5):465-72. PubMed ID: 23907518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy for unresectable recurrent and in-transit extremity melanoma.
    Gimbel MI; Delman KA; Zager JS
    Cancer Control; 2008 Jul; 15(3):225-32. PubMed ID: 18596674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional therapies for in-transit disease.
    Speicher PJ; Meriwether CH; Tyler DS
    Surg Oncol Clin N Am; 2015 Apr; 24(2):309-22. PubMed ID: 25769714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Locoregional therapies in melanoma.
    Abbott AM; Zager JS
    Surg Clin North Am; 2014 Oct; 94(5):1003-15, viii. PubMed ID: 25245964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastatic melanoma in a patient with Clouston syndrome successfully treated with isolated hyperthermic limb perfusion.
    Parhizkar N; Jones VE; McClay EF; Yi ES; Bouvet M
    J Cutan Med Surg; 2003; 7(1):43-6. PubMed ID: 12362262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Locoregional recurrence of melanomas of the extremities after hyperthermic extremity perfusion: is reperfusion of value?].
    Meyer T; Göhl J; Hohenberger W
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1452-4. PubMed ID: 9931909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-transit melanoma: an individualized approach.
    Grotz TE; Mansfield AS; Kottschade LA; Erickson LA; Otley CC; Markovic SN; Jakub JW
    Oncology (Williston Park); 2011 Dec; 25(14):1340-8. PubMed ID: 22329185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of Locoregionally Advanced Melanoma.
    Pointer DT; Zager JS
    Surg Clin North Am; 2020 Feb; 100(1):109-125. PubMed ID: 31753106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologic behavior and treatment of intransit metastasis of melanoma.
    Karakousis CP; Choe KJ; Holyoke ED
    Surg Gynecol Obstet; 1980 Jan; 150(1):29-32. PubMed ID: 7350699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and treatment of in-transit melanoma metastases.
    Testori A; Ribero S; Bataille V
    Eur J Surg Oncol; 2017 Mar; 43(3):544-560. PubMed ID: 27923593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanoma of the extremities--long-term follow-up of a randomised trial.
    Olofsson Bagge R; Mattsson J; Hafström L
    Int J Hyperthermia; 2014 Aug; 30(5):295-8. PubMed ID: 25144818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperthermic antiblastic perfusion in the treatment of local recurrence or "in-transit" metastases of limb melanoma.
    Cavaliere R; Di Filippo F; Giannarelli D; Carlini S; Anzà M; Cavaliere F; Graziano F; Perri P
    Semin Surg Oncol; 1992; 8(6):374-80. PubMed ID: 1439448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicity of hyperthermic isolated limb perfusion with cisplatin for recurrent melanoma of the lower extremity after previous perfusion treatment.
    Hoekstra HJ; Schraffordt Koops H; de Vries LG; van Weerden TW; Oldhoff J
    Cancer; 1993 Aug; 72(4):1224-9. PubMed ID: 8393368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolated limb perfusion for unresectable melanoma of the extremities.
    Noorda EM; Vrouenraets BC; Nieweg OE; van Geel BN; Eggermont AM; Kroon BB
    Arch Surg; 2004 Nov; 139(11):1237-42. PubMed ID: 15545572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Locoregional cutaneous metastases of malignant melanoma and their management.
    Wolf IH; Richtig E; Kopera D; Kerl H
    Dermatol Surg; 2004 Feb; 30(2 Pt 2):244-7. PubMed ID: 14871216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Commentary on pharmacotherapy of regional melanoma therapy.
    Zager JS; Delman KA
    Expert Opin Pharmacother; 2010 Jan; 11(1):1-3. PubMed ID: 20001424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of therapeutic hyperthermic limb perfusion in advanced recurrent melanoma of the lower extremity.
    Storm FK; Morton DL
    Am J Surg; 1985 Jul; 150(1):32-5. PubMed ID: 4014570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical treatment options for stage IV melanoma.
    Wei IH; Healy MA; Wong SL
    Surg Clin North Am; 2014 Oct; 94(5):1075-89, ix. PubMed ID: 25245969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of regional hyperthermic perfusion for primary and recurrent melanomas of the extremities.
    Jönsson PE; Hafström L; Hugander A
    Recent Results Cancer Res; 1983; 86():277-82. PubMed ID: 6648009
    [No Abstract]   [Full Text] [Related]  

  • 20. Isolated limb perfusion: what is the evidence for its use?
    Noorda EM; Vrouenraets BC; Nieweg OE; Van Coevorden F; Kroon BB
    Ann Surg Oncol; 2004 Sep; 11(9):837-45. PubMed ID: 15313738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.